Clinical Trial: Transcriptomics Signature of Anti Vaccinia Memory B Cells

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Observational

Official Title: Transcriptomics Signature of Anti Vaccinia Memory B Cells in Healthy Individuals at a Short Time After Vaccination

Brief Summary: Analyse the transcriptomic signature of anti vaccinia memory B cells at a short time after vaccination as compared to the signature already established in long-lived memory B cells.

Detailed Summary:
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

Current Primary Outcome: signature of anti vaccinia long-lived memory B cells [ Time Frame: 12 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Institut National de la Santé Et de la Recherche Médicale, France

Dates:
Date Received: September 21, 2015
Date Started: September 2015
Date Completion: September 2016
Last Updated: September 29, 2015
Last Verified: May 2015